These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 1372585)
1. Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells. Yajima S; Suzuki Y; Shimozawa N; Yamaguchi S; Orii T; Fujiki Y; Osumi T; Hashimoto T; Moser HW Hum Genet; 1992 Mar; 88(5):491-9. PubMed ID: 1372585 [TBL] [Abstract][Full Text] [Related]
2. Genetic relationship between the Zellweger syndrome and other peroxisomal disorders characterized by an impairment in the assembly of peroxisomes. Tager JM; Brul S; Wiemer EA; Strijland A; Van Driel R; Schutgens RB; Van den Bosch H; Wanders RJ; Westerveld A Prog Clin Biol Res; 1990; 321():545-58. PubMed ID: 2183242 [TBL] [Abstract][Full Text] [Related]
3. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. Slawecki ML; Dodt G; Steinberg S; Moser AB; Moser HW; Gould SJ J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797 [TBL] [Abstract][Full Text] [Related]
4. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients. Roscher AA; Hoefler S; Hoefler G; Paschke E; Paltauf F; Moser A; Moser H Pediatr Res; 1989 Jul; 26(1):67-72. PubMed ID: 2475849 [TBL] [Abstract][Full Text] [Related]
5. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders]. Suzuki Y No To Hattatsu; 1992 Mar; 24(2):194-7. PubMed ID: 1373633 [TBL] [Abstract][Full Text] [Related]
6. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders. Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966 [TBL] [Abstract][Full Text] [Related]
7. Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders. Hughes JL; Crane DI; Robertson E; Poulos A Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):459-68. PubMed ID: 7507276 [TBL] [Abstract][Full Text] [Related]
8. Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis. Brul S; Westerveld A; Strijland A; Wanders RJ; Schram AW; Heymans HS; Schutgens RB; van den Bosch H; Tager JM J Clin Invest; 1988 Jun; 81(6):1710-5. PubMed ID: 2454948 [TBL] [Abstract][Full Text] [Related]
10. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. Moser AB; Rasmussen M; Naidu S; Watkins PA; McGuinness M; Hajra AK; Chen G; Raymond G; Liu A; Gordon D J Pediatr; 1995 Jul; 127(1):13-22. PubMed ID: 7541833 [TBL] [Abstract][Full Text] [Related]
11. Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome. Shimozawa N; Tsukamoto T; Suzuki Y; Orii T; Fujiki Y J Clin Invest; 1992 Nov; 90(5):1864-70. PubMed ID: 1430210 [TBL] [Abstract][Full Text] [Related]
12. Pathology of hepatic peroxisomes and mitochondria in patients with peroxisomal disorders. Hughes JL; Poulos A; Robertson E; Chow CW; Sheffield LJ; Christodoulou J; Carter RF Virchows Arch A Pathol Anat Histopathol; 1990; 416(3):255-64. PubMed ID: 1689088 [TBL] [Abstract][Full Text] [Related]
13. [Clinical and molecular aspects of peroxisome-deficient disorders]. Suzuki Y; Shimozawa N; Orii T Nihon Rinsho; 1993 Sep; 51(9):2353-8. PubMed ID: 7692118 [TBL] [Abstract][Full Text] [Related]